Cargando…
Tauroursodeoxycholic Acid (TUDCA)—Lipid Interactions and Antioxidant Properties of TUDCA Studied in Model of Photoreceptor Membranes
Tauroursodeoxycholic acid (TUDCA), a hydrophilic bile acid containing taurine conjugated with the ursodeoxycholic acid (UDCA), has been known and used from ancient times as a therapeutic compound in traditional Chinese medicine. TUDCA has recently been gaining significant interest as a neuroprotecti...
Autores principales: | Sabat, Michał J., Wiśniewska-Becker, Anna M., Markiewicz, Michał, Marzec, Katarzyna M., Dybas, Jakub, Furso, Justyna, Pabisz, Paweł, Duda, Mariusz, Pawlak, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146903/ https://www.ncbi.nlm.nih.gov/pubmed/33946822 http://dx.doi.org/10.3390/membranes11050327 |
Ejemplares similares
-
Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment
por: Mantopoulos, Dimosthenis, et al.
Publicado: (2011) -
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022) -
Tauroursodeoxycholic acid (TUDCA) alleviates endoplasmic reticulum stress of nuclear donor cells under serum starvation
por: Zhang, Ying, et al.
Publicado: (2018) -
Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress
por: Rani, Shilpa, et al.
Publicado: (2017) -
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
por: Lombardo, Flavia L., et al.
Publicado: (2023)